Co-Diagnostics, Inc.
CODXNASDAQHealthcare● Active
$5.13
$-0.51(-8.97%)
Market Cap$5720761
P/E Ratio—
52W High$46.5
52W Low$1.26
Co-Diagnostics, Inc. (CODX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CODX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.62M | $3.92M | $6.81M | $34.22M | $97.89M |
| Cost of Revenue | $0.22M | $1.00M | $4.18M | $5.48M | $11.57M |
| Gross Profit | $0.40M | $2.92M | $2.63M | $28.74M | $86.31M |
| Gross Margin %(computed) | 64.28% | 74.48% | 38.57% | 83.98% | 88.18% |
| Operating Expenses | |||||
| R&D Expenses | $19.14M | $20.98M | $22.96M | $17.44M | $14.96M |
| G&A Expenses | $9.06M | $16.16M | $14.28M | $14.26M | $11.55M |
| Total Operating Expenses | $31.68M | $43.00M | $45.33M | $55.72M | $40.25M |
| Operating Income | ($31.28M) | ($40.08M) | ($42.71M) | ($26.98M) | $46.06M |
| Operating Margin %(computed) | — | — | -626.92% | -78.85% | 47.06% |
| Interest Income | $0.29M | $1.09M | $1.16M | $0.70M | $0.05M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($48.51M) | ($37.58M) | ($38.11M) | ($18.85M) | $45.64M |
| Income Tax Expense | ($1.62M) | $0.06M | ($2.78M) | ($4.61M) | $8.98M |
| Net Income | ($46.90M) | ($37.64M) | ($35.33M) | ($14.24M) | $36.66M |
| Net Margin %(computed) | — | -961.37% | -518.68% | -41.61% | 37.45% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-35.25 | $-37.20 | $-36.00 | $-13.57 | $38.10 |
| Wtd Avg Shares | 1.33M | 1.01M | 0.98M | 1.05M | 0.96M |
| EBITDA | ($30.18M) | ($38.70M) | ($41.48M) | ($10.31M) | $46.40M |
| EBITDA Margin %(computed) | — | -988.57% | -608.86% | -30.13% | 47.40% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Co-Diagnostics, Inc. data
About Co-Diagnostics, Inc. (CODX) Income Statement
Co-Diagnostics, Inc. (CODX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CODX reported revenue of $0.00B, gross profit of $0.00B (gross margin 64.28%), and net income of ($0.05B) — a net profit margin of -7533.62%.
Frequently asked questions
CODX · 4 questionsCo-Diagnostics, Inc. (CODX) reported revenue of $0.00B for 2025, down 84.1% year-over-year.
CODX revenueCODX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08